Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 11/2022

15-09-2022 | Septicemia | Original Article

Comparison between culture-positive and culture-negative septic shock in patients in the emergency department

Authors: Choon-Bing Chua, Chi-Chieh Hung, Yong-Ye Yang, Tsung-Han Wang, Yin-Chou Hsu

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 11/2022

Login to get access

Abstract

Culture results of patients with septic shock affect their management strategies, including antibiotic administration. This study aimed to compare clinical characteristics and outcomes of patients with culture-negative septic shock (CNSS) and culture-positive septic shock (CPSS) in the emergency department. We also assessed the differences in duration and de-escalation timing of antibiotic administration between the two groups. This single-center, retrospective, case–control study included adult patients diagnosed with septic shock in the emergency department between January 1, 2019 and March 31, 2020. They were divided into the CNSS and CPSS groups based on their culture results. The baseline characteristics, infection sites, culture types, and clinical outcomes were recorded and compared. Patients with CPSS (63.7%, 311/488) and CNSS (36.3%, 177/488) were identified. The CPSS and CNSS groups had comparable clinical outcomes, including mechanical ventilation (29.6% vs. 32.8%, p = 0.46), renal replacement therapy (19.3% vs. 23.2%, p = 0.31), 30-day mortality (35.7% vs. 36.7%, p = 0.82), and in-hospital mortality (39.5% vs. 41.8%, p = 0.63). The CNSS group had a significantly shorter duration (13 [8 − 19] vs. 16 [10 − 23], days, p = 0.04) and earlier de-escalation timing (5 [2 − 9] vs. 9 [7 − 12], day, p = 0.02) of antibiotic administration than the CPSS group. Patients with CNSS and CPSS had similar clinical characteristics and proportion of adverse outcomes. Physicians can evaluate the feasibility of early de-escalation or discontinuation of antibiotic administration in patients with CNSS showing clinical improvement.
Literature
1.
go back to reference Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche J-D, Coopersmith CM (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):801–810CrossRef Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche J-D, Coopersmith CM (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):801–810CrossRef
2.
go back to reference Mayr FB, Yende S, Angus DC (2014) Epidemiol Severe Sepsis Virulence 5(1):4–11 Mayr FB, Yende S, Angus DC (2014) Epidemiol Severe Sepsis Virulence 5(1):4–11
3.
go back to reference Vincent J-L, Jones G, David S, Olariu E, Cadwell KK (2019) Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis. Crit Care 23(1):1–11CrossRef Vincent J-L, Jones G, David S, Olariu E, Cadwell KK (2019) Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis. Crit Care 23(1):1–11CrossRef
4.
go back to reference Kim J-s, Kim Y-J, Kim WY (2021) Characteristics and clinical outcomes of culture-negative and culture-positive septic shock: a single-center retrospective cohort study. Crit Care 25(1):1–9CrossRef Kim J-s, Kim Y-J, Kim WY (2021) Characteristics and clinical outcomes of culture-negative and culture-positive septic shock: a single-center retrospective cohort study. Crit Care 25(1):1–9CrossRef
5.
go back to reference Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, Mcintyre L, Ostermann M, Prescott HC (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 47(11):1181–1247CrossRef Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, Mcintyre L, Ostermann M, Prescott HC (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 47(11):1181–1247CrossRef
6.
go back to reference Li Y, Guo J, Yang H, Li H, Shen Y, Zhang D (2021) Comparison of culture-negative and culture-positive sepsis or septic shock: a systematic review and meta-analysis. Crit Care 25(1):1–9CrossRef Li Y, Guo J, Yang H, Li H, Shen Y, Zhang D (2021) Comparison of culture-negative and culture-positive sepsis or septic shock: a systematic review and meta-analysis. Crit Care 25(1):1–9CrossRef
7.
go back to reference Gupta S, Sakhuja A, Kumar G, McGrath E, Nanchal RS, Kashani KB (2016) Culture-negative severe sepsis: nationwide trends and outcomes. Chest 150(6):1251–1259CrossRef Gupta S, Sakhuja A, Kumar G, McGrath E, Nanchal RS, Kashani KB (2016) Culture-negative severe sepsis: nationwide trends and outcomes. Chest 150(6):1251–1259CrossRef
8.
go back to reference Kethireddy S, Bilgili B, Sees A, Kirchner HL, Ofoma UR, Light RB, Mirzanejad Y, Maki D, Kumar A, Layon AJ (2018) Culture-negative septic shock compared with culture-positive septic shock: a retrospective cohort study. Crit Care Med 46(4):506–512CrossRef Kethireddy S, Bilgili B, Sees A, Kirchner HL, Ofoma UR, Light RB, Mirzanejad Y, Maki D, Kumar A, Layon AJ (2018) Culture-negative septic shock compared with culture-positive septic shock: a retrospective cohort study. Crit Care Med 46(4):506–512CrossRef
9.
go back to reference Sigakis MJ, Jewell E, Maile MD, Cinti SK, Bateman BT, Engoren M (2019) Culture negative and culture positive sepsis: a comparison of characteristics and outcomes. Anesth Analg 129(5):1300CrossRef Sigakis MJ, Jewell E, Maile MD, Cinti SK, Bateman BT, Engoren M (2019) Culture negative and culture positive sepsis: a comparison of characteristics and outcomes. Anesth Analg 129(5):1300CrossRef
10.
go back to reference Paquette K, Sweet D, Stenstrom R, Stabler SN, Lawandi A, Akhter M, Davidson AC, Gavric M, Jinah R, Saeed Z (2021) Neither blood culture positivity nor time to positivity is associated with mortality among patients presenting with severe manifestations of sepsis: the FABLED cohort study. Open Forum Infect Dis 8(7):ofab321CrossRef Paquette K, Sweet D, Stenstrom R, Stabler SN, Lawandi A, Akhter M, Davidson AC, Gavric M, Jinah R, Saeed Z (2021) Neither blood culture positivity nor time to positivity is associated with mortality among patients presenting with severe manifestations of sepsis: the FABLED cohort study. Open Forum Infect Dis 8(7):ofab321CrossRef
11.
go back to reference Gray A, Ward K, Lees F, Dewar C, Dickie S, McGuffie C (2013) The epidemiology of adults with severe sepsis and septic shock in Scottish emergency departments. Emerg Med J 30(5):397–401CrossRef Gray A, Ward K, Lees F, Dewar C, Dickie S, McGuffie C (2013) The epidemiology of adults with severe sepsis and septic shock in Scottish emergency departments. Emerg Med J 30(5):397–401CrossRef
12.
go back to reference Yu C-W, Chang S-S, Lai C-C, Wu J-Y, Yen DW, M-tG L, Yeh C-C, Chung J-Y, Lin Y-J, Lee C-C (2019) Epidemiology of emergency department sepsis: a national cohort study between 2001 and 2012. Shock 51(5):619–624CrossRef Yu C-W, Chang S-S, Lai C-C, Wu J-Y, Yen DW, M-tG L, Yeh C-C, Chung J-Y, Lin Y-J, Lee C-C (2019) Epidemiology of emergency department sepsis: a national cohort study between 2001 and 2012. Shock 51(5):619–624CrossRef
13.
go back to reference Armstrong-Briley D, Hozhabri NS, Armstrong K, Puthottile J, Benavides R, Beal S (2015) Comparison of length of stay and outcomes of patients with positive versus negative blood culture results. Proc (Bayl Univ Med Cent) 28(1):10–13 Armstrong-Briley D, Hozhabri NS, Armstrong K, Puthottile J, Benavides R, Beal S (2015) Comparison of length of stay and outcomes of patients with positive versus negative blood culture results. Proc (Bayl Univ Med Cent) 28(1):10–13
14.
go back to reference Klompas M, Calandra T, Singer M (2018) Antibiotics for sepsis—finding the equilibrium. JAMA 320(14):1433–1434CrossRef Klompas M, Calandra T, Singer M (2018) Antibiotics for sepsis—finding the equilibrium. JAMA 320(14):1433–1434CrossRef
15.
go back to reference Thorndike J, Kollef MH (2020) Culture-negative sepsis. Curr Opin Criti Care 26(5):473–477CrossRef Thorndike J, Kollef MH (2020) Culture-negative sepsis. Curr Opin Criti Care 26(5):473–477CrossRef
16.
go back to reference Opota O, Croxatto A, Prod’hom G, Greub G (2015) Blood culture-based diagnosis of bacteraemia: state of the art. Clin Microbiol Infect 21(4):313–322CrossRef Opota O, Croxatto A, Prod’hom G, Greub G (2015) Blood culture-based diagnosis of bacteraemia: state of the art. Clin Microbiol Infect 21(4):313–322CrossRef
17.
go back to reference Tabah A, Bassetti M, Kollef MH, Zahar J-R, Paiva J-A, Timsit J-F, Roberts JA, Schouten J, Giamarellou H, Rello J (2020) Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP). Intensive Care Med 46(2):245–265CrossRef Tabah A, Bassetti M, Kollef MH, Zahar J-R, Paiva J-A, Timsit J-F, Roberts JA, Schouten J, Giamarellou H, Rello J (2020) Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP). Intensive Care Med 46(2):245–265CrossRef
18.
go back to reference Garnacho-Montero J, Escoresca-Ortega A, Fernández-Delgado E (2015) Antibiotic de-escalation in the ICU: how is it best done? Curr Opin Infect Dis 28(2):193–198CrossRef Garnacho-Montero J, Escoresca-Ortega A, Fernández-Delgado E (2015) Antibiotic de-escalation in the ICU: how is it best done? Curr Opin Infect Dis 28(2):193–198CrossRef
19.
go back to reference Kaukonen K-M, Bailey M, Pilcher D, Cooper DJ, Bellomo R (2015) Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med 372(17):1629–1638CrossRef Kaukonen K-M, Bailey M, Pilcher D, Cooper DJ, Bellomo R (2015) Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med 372(17):1629–1638CrossRef
20.
go back to reference Ferreira FL, Bota DP, Bross A, Mélot C, Vincent J-L (2001) Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 286(14):1754–1758CrossRef Ferreira FL, Bota DP, Bross A, Mélot C, Vincent J-L (2001) Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 286(14):1754–1758CrossRef
21.
go back to reference Allison MG, Heil EL, Hayes BD (2017) Appropriate antibiotic therapy. Emerg Med Clin North Am 35(1):25–42CrossRef Allison MG, Heil EL, Hayes BD (2017) Appropriate antibiotic therapy. Emerg Med Clin North Am 35(1):25–42CrossRef
22.
go back to reference Scheer C, Fuchs C, Gründling M, Vollmer M, Bast J, Bohnert J, Zimmermann K, Hahnenkamp K, Rehberg S, Kuhn S-O (2019) Impact of antibiotic administration on blood culture positivity at the beginning of sepsis: a prospective clinical cohort study. Clin Microbiol Infect 25(3):326–331CrossRef Scheer C, Fuchs C, Gründling M, Vollmer M, Bast J, Bohnert J, Zimmermann K, Hahnenkamp K, Rehberg S, Kuhn S-O (2019) Impact of antibiotic administration on blood culture positivity at the beginning of sepsis: a prospective clinical cohort study. Clin Microbiol Infect 25(3):326–331CrossRef
23.
go back to reference Lin G-L, McGinley JP, Drysdale SB, Pollard AJ (2018) Epidemiology and immune pathogenesis of viral sepsis. Front Immunol 9:2147CrossRef Lin G-L, McGinley JP, Drysdale SB, Pollard AJ (2018) Epidemiology and immune pathogenesis of viral sepsis. Front Immunol 9:2147CrossRef
24.
go back to reference Phua J, Ngerng WJ, See KC, Tay CK, Kiong T, Lim HF, Chew MY, Yip HS, Tan A, Khalizah HJ (2013) Characteristics and outcomes of culture-negative versus culture-positive severe sepsis. Crit Care 17(5):1–12CrossRef Phua J, Ngerng WJ, See KC, Tay CK, Kiong T, Lim HF, Chew MY, Yip HS, Tan A, Khalizah HJ (2013) Characteristics and outcomes of culture-negative versus culture-positive severe sepsis. Crit Care 17(5):1–12CrossRef
25.
go back to reference Scott MC (2017) Defining and diagnosing sepsis. Emerg Med Clin North Am 35(1):1–9CrossRef Scott MC (2017) Defining and diagnosing sepsis. Emerg Med Clin North Am 35(1):1–9CrossRef
26.
go back to reference Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP, Artigas A, Schorr C, Levy MM (2014) Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 42(8):1749–1755CrossRef Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP, Artigas A, Schorr C, Levy MM (2014) Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 42(8):1749–1755CrossRef
27.
go back to reference Alam N, Oskam E, Stassen PM, van Exter P, van de Ven PM, Haak HR, Holleman F, van Zanten A, van Leeuwen-Nguyen H, Bon V (2018) Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial. Lancet Respir Med 6(1):40–50CrossRef Alam N, Oskam E, Stassen PM, van Exter P, van de Ven PM, Haak HR, Holleman F, van Zanten A, van Leeuwen-Nguyen H, Bon V (2018) Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial. Lancet Respir Med 6(1):40–50CrossRef
28.
go back to reference Mignot-Evers L, Raaijmakers V, Buunk G, Brouns S, Romano L, van Herpt T, Gharbharan A, Dieleman J, Haak H (2021) Comparison of SIRS criteria and qSOFA score for identifying culture-positive sepsis in the emergency department: a prospective cross-sectional multicentre study. BMJ Open 11(6):e041024CrossRef Mignot-Evers L, Raaijmakers V, Buunk G, Brouns S, Romano L, van Herpt T, Gharbharan A, Dieleman J, Haak H (2021) Comparison of SIRS criteria and qSOFA score for identifying culture-positive sepsis in the emergency department: a prospective cross-sectional multicentre study. BMJ Open 11(6):e041024CrossRef
29.
go back to reference Chiu I-M, Huang Y-H, Su C-M, Kung C-T, Li C-J, Chen C-H, Tang K-S, Kuo K-C (2020) C-Reactive protein concentration can help to identify bacteremia in children visiting the emergency department: a single medical center experience. Pediatr Emerg Care 36(6):291–295PubMed Chiu I-M, Huang Y-H, Su C-M, Kung C-T, Li C-J, Chen C-H, Tang K-S, Kuo K-C (2020) C-Reactive protein concentration can help to identify bacteremia in children visiting the emergency department: a single medical center experience. Pediatr Emerg Care 36(6):291–295PubMed
30.
go back to reference Wu Q, Yang H, Kang Y (2018) Comparison of diagnostic accuracy among procalcitonin, C-reactive protein, and interleukin 6 for blood culture positivity in general ICU patients. Crit Care 22(1):1–2CrossRef Wu Q, Yang H, Kang Y (2018) Comparison of diagnostic accuracy among procalcitonin, C-reactive protein, and interleukin 6 for blood culture positivity in general ICU patients. Crit Care 22(1):1–2CrossRef
Metadata
Title
Comparison between culture-positive and culture-negative septic shock in patients in the emergency department
Authors
Choon-Bing Chua
Chi-Chieh Hung
Yong-Ye Yang
Tsung-Han Wang
Yin-Chou Hsu
Publication date
15-09-2022
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 11/2022
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-022-04496-3

Other articles of this Issue 11/2022

European Journal of Clinical Microbiology & Infectious Diseases 11/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine